Literature DB >> 103356

Screening coagulation tests and clotting factors in homozygous beta-thalassemia.

L Caocci, M Alberti, P Burrai, R Corda.   

Abstract

In 30 children with homozygous beta-thalassemia the hemostasis screening tests (bleeding time, PT, PTT), platelet count and specific assays of clotting factors were carried out 25 days after their last transfusion. PT, PTT, and bleeding time showed minor variations; considerable thrombocytosis was found in splenectomized patients. Factors IX and XII were decreased in a high proportion of patients, the vitamin K-dependent factors (II, VII, IX, X) were slightly reduced and factors I, V and VIII remained within the normal range in a majority of patients. Hepatic failure resulting in defective protein synthesis does not explain the more marked impairment of factors XI and XII, which might be secondary to activation of the intrinsic coagulation and/or kallikrein systems following intravascular haemolysis and multiple blood transfusions.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 103356     DOI: 10.1159/000207735

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  2 in total

1.  Thrombin Activable Fibrinolysis Inhibitor in Beta Thalassemia.

Authors:  Aruna Chhikara; Sunita Sharma; Jagdish Chandra; Anita Nangia
Journal:  Indian J Pediatr       Date:  2016-08-03       Impact factor: 1.967

2.  Subclinical haemorrhagic tendency exists in patients with β-thalassaemia major in early childhood.

Authors:  Abhishek Maiti; Amartya Chakraborti; Puranjoy Chakraborty; Sanjay Mishra
Journal:  Australas Med J       Date:  2012-02-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.